Boldebolic 200 mg/mL — Product Overview
Boldebolic is an injectable anabolic-androgenic steroid (AAS) product identified in the supplied catalog information as containing boldenone undecylenate at a concentration of 200 mg/mL. It is presented in a 10 mL vial, corresponding to a nominal total of 2,000 mg of boldenone undecylenate per vial.
The Roidsdeal listing identifies Nitro Labs as the manufacturer, while the accompanying descriptions reference Nitro Pro Bolic. This discrepancy requires confirmation against the original packaging or manufacturer documentation.
Boldenone undecylenate is a long-acting ester of boldenone, a synthetic androgen. Its pharmacological properties, veterinary background, and potential adverse effects are important considerations when evaluating this substance.
What Is Boldebolic?
Boldebolic is the product name associated with a formulation containing boldenone undecylenate.
Boldenone is a synthetic anabolic-androgenic steroid structurally related to testosterone. The undecylenate ester modifies the compound’s release characteristics after administration, allowing the active steroid to become available gradually.
Boldenone undecylenate has historically been used in veterinary medicine, particularly in horses. Its veterinary background should not be confused with authorization for human medical treatment.
The compound is also associated with nonmedical performance-enhancement use, although such use carries significant health risks and is prohibited under anti-doping rules.
The regulatory status of the specific Boldebolic brand has not been established from the supplied information.
How Does Boldenone Undecylenate Work?
Boldenone produces androgenic and anabolic effects through interactions with androgen receptors.
After an esterified formulation is administered, the ester is gradually cleaved, releasing active boldenone. The released compound can bind to androgen receptors and influence androgen-responsive gene expression in various tissues.
Androgen receptor signaling is involved in several physiological processes, including protein metabolism, reproductive function, and the development and maintenance of androgen-dependent tissues.
The undecylenate ester contributes to prolonged release characteristics compared with unesterified boldenone. However, the exact release profile depends on the formulation and other factors.
These pharmacological mechanisms do not establish that a particular commercial product is effective, safe, or suitable for human use.
No product-specific pharmacokinetic studies for Boldebolic were provided.
Medical Uses and Clinical Information
Boldenone undecylenate has a documented history in veterinary medicine, where certain formulations have been used under veterinary supervision.
It is not an FDA-approved medication for human use in the United States.
Although anabolic-androgenic steroids have legitimate medical applications as a broader drug class, the indications of approved medications cannot automatically be attributed to boldenone undecylenate or to Boldebolic.
There is insufficient established human clinical evidence to support claims that this specific product safely improves athletic performance, physical appearance, or recovery.
Nonmedical exposure to anabolic-androgenic steroids may cause endocrine, cardiovascular, reproductive, hepatic, and psychological complications.
Clinical evaluation of suspected adverse effects requires consideration of the individual’s medical history, other medications, laboratory findings, and potential exposure to additional substances.
Product Specifications and Packaging
The following specifications are taken from the supplied product information and should be checked against the physical product label.
Specification Product Details
Product Name Boldebolic
Active Ingredient Boldenone Undecylenate
Listed Manufacturer Nitro Labs
Concentration 200 mg/mL
Product Form Injectable Solution
Package Size 10 mL Vial
Nominal Total Content 2,000 mg
Pharmacological Class Anabolic-Androgenic Steroid
Ester Undecylenate
The supplied descriptions do not establish the complete excipient composition, manufacturing location, batch identification system, or independently verified quality-control standards.
Administration and Medical Supervision
Boldenone undecylenate is generally associated with intramuscular injectable formulations. The intended administration route for this specific product should be confirmed using authentic labeling.
Injectable anabolic-androgenic steroids introduce risks beyond the systemic effects of the active ingredient. These include injection-site reactions, infection, contamination, and complications associated with inappropriate administration.
Human use of veterinary anabolic steroids should not be assumed safe.
Medical assessment following exposure may include cardiovascular evaluation, blood pressure measurement, complete blood counts, lipid testing, liver function assessment, and evaluation of hormonal disturbances.
No human dosing schedule, injection frequency, or performance-enhancement regimen can be established from the supplied product information.
Possible Side Effects of Boldenone Undecylenate
Boldenone shares pharmacological characteristics with other anabolic-androgenic steroids. Its potential adverse effects include complications associated with androgen exposure and suppression of normal hormonal regulation.
Hormonal and Reproductive Effects
Potential effects include:
– Suppression of natural testosterone production
– Reduced sperm production and impaired fertility
– Testicular atrophy
– Acne and increased skin oiliness
– Androgen-related hair loss
– Menstrual disturbances and virilization in females
Some reproductive or virilizing effects may persist after exposure ends.
Cardiovascular and Blood-Related Risks
Anabolic-androgenic steroid exposure may be associated with unfavorable cholesterol changes, elevated blood pressure, increased hematocrit, and cardiovascular complications.
Increased red blood cell concentration can raise concerns about blood viscosity and thrombotic risk.
Serious cardiovascular outcomes associated with anabolic steroid misuse include heart attack, stroke, and cardiomyopathy.
Psychological and Other Effects
Potential effects include mood disturbances, irritability, anxiety, and changes in behavior.
Liver abnormalities and other systemic complications may also occur, particularly when multiple anabolic substances are used.
Severe chest pain, breathing difficulties, sudden neurological symptoms, or significant injection-site swelling accompanied by fever require urgent medical attention.
The frequency and severity of these effects cannot be reliably quantified for Boldebolic without product-specific clinical evidence.
Warnings and Precautions
Boldenone undecylenate should not be considered a routine human therapeutic option.
Individuals with cardiovascular disease, abnormal blood counts, liver or kidney disorders, hormone-sensitive conditions, or reproductive health concerns may face particular risks from anabolic-androgenic steroid exposure.
Exposure during pregnancy presents potential risks to fetal development. Androgenic substances may also cause irreversible virilizing changes.
Interactions with other medications, including anticoagulants and certain diabetes treatments, may require medical evaluation.
Combining anabolic steroids with additional hormonal substances can complicate adverse-effect assessment and increase health risks.
Athletes should also be aware that boldenone is prohibited under the World Anti-Doping Agency’s anabolic-agent rules.
Storage and Handling
The supplied descriptions do not specify verified storage temperatures, shelf life, or light-protection requirements for Boldebolic.
Storage conditions should therefore be determined from authentic manufacturer labeling rather than assumed from other injectable products.
The vial should not be used if its identity, integrity, expiration date, or sterility is uncertain.
Injectable preparations require appropriate sterile handling and must not be shared between individuals.
Frequently Asked Questions
What is the active ingredient in Boldebolic?
The listed active ingredient is boldenone undecylenate, an esterified anabolic-androgenic steroid.
What concentration does Boldebolic contain?
The supplied product information specifies 200 mg/mL.
What is the package size?
Boldebolic is listed as a 10 mL vial.
Is Boldebolic approved for human medical use?
No human regulatory approval for this branded product has been verified. Boldenone undecylenate is not FDA-approved for human use in the United States.
Conclusion and Medical Disclaimer
Boldebolic is listed as a 200 mg/mL boldenone undecylenate injectable product. Medical decisions require qualified professional guidance.
PART 3 — VERIFICATION NOTES
The following details require review before publication:
1. Manufacturer discrepancy: Roidsdeal identifies Nitro Labs, while both long descriptions reference Nitro Pro Bolic. The correct legal manufacturer or brand must be confirmed.
2. Concentration and packaging: The 200 mg/mL concentration and 10 mL vial are supported by the Roidsdeal listing but have not been independently verified.
3. Formulation: The oil-based formulation and intramuscular route are consistent with conventional boldenone undecylenate preparations but are not confirmed by the supplied product label.
4. Quality claims: Statements about guaranteed purity, rigorous quality controls, superior standards, and consistent safety were excluded because supporting documentation was not provided.
5. Regulatory status: No specific marketing authorization, human prescription classification, or manufacturer-approved storage instructions were established for Boldebolic.
The description is prepared as neutral, informational WooCommerce catalog content, subject to manufacturer and regulatory verification before publication.




Reviews
There are no reviews yet.